Skip to content
People

Parinaz Motamedy

Director at GelMEDIX.

Earliest Form D on file: Apr 2026

Filed Apr 30, 2026Amendment

GelMEDIX

Hydrogel-delivered cell therapy for geographic atrophy

Biotech, Cambridge MA

Named, Director.

$747K

sold of $2.5M offered

Form D

Reported on an amendment to an earlier filing.

Network

At GelMEDIX

4 people